BMI1 INTERACTING PROTEINS IN NEOPLASTIC TRANSFORMATION
BMI1 INTERACTING PROTEINS IN NEOPLASTIC TRANSFORMATION
批准号:
6513258
负责人:
Charles Stanley Hemenway
金额:
$14.03万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-02 至 2003-06-30
中文摘要
Bmi-1是一种环指癌蛋白,与老鼠和猫的淋巴瘤发展有关。过表达Bmi-1导致细胞转化。Bmi-1是由Polycomb蛋白群(PcG)组成的一个庞大的异质蛋白家族的成员。PcG基因最初在果蝇中被鉴定为正常胚胎发生的关键介质。随后的研究表明,PcG蛋白形成大的多聚体复合物,使基因表达沉默。为了了解Bmi-1的功能,我们试图鉴定含有Bmi-1的哺乳动物蛋白复合物的成分。我们发现Bmi-1直接与另一种无名指蛋白dinG相互作用。Bmi-1环指结构域突变使该蛋白非淋巴瘤原性和非转化性。重要的是,我们发现环指结构域的突变阻止了Bmi-1结合dinG。这表明在bmi -1诱导的淋巴瘤中可能需要bmi -1-丁异二聚化。我们已经鉴定出一种新的PcG蛋白MPc3,它可以与丁基丁基蛋白相互作用。初步资料表明MPc3被Bmi-1从丁基偏移。dinG和MPc3之间相互作用的破坏依赖于完好的Bmi-1无名指。因此,非转化的突变体Bmi-1蛋白预计无法破坏dinG-MPc3二聚体。这一发现表明PcG蛋白之间的动态相互作用可能是由Bmi-1引起的细胞转化的基础。基于Bmi-1环指结构域在诱导细胞转化、结合dinG和取代MPc3中的重要性,我们建议研究dinG和MPc3在Bmi-1介导的肿瘤事件中的潜在作用。我们将检验Bmi-1- ding异源二聚化是由Bmi-1引起的细胞转化所必需的假设。我们还将研究Bmi-1的过表达是否可能通过结合dinG并同时取代MPc3来改变PcG复合物的组成。
英文摘要
Bmi-1 is a RING finger oncoprotein that has been linked to the development of lymphomas in mice and cats. Overexpression of Bmi-1 results in cellular transformation. Bmi-1 is a member of a large and heterogeneous family of proteins that comprise the Polycomb group (PcG). PcG genes were initially identified in Drosophila as critical mediators of normal embryogenesis. Subsequent studies have demonstrated that PcG proteins form large multimeric complexes that silence gene expression. In order to understand the function of Bmi-1, we have sought to identify components of mammalian protein complexes that contain Bmi-1. We have found that Bmi-1 directly interacts with another RING finger protein, dinG. Bmi-1 RING finger domain mutations render the protein non-lymphomagenic and non-transforming. Importantly, we find that mutations in the RING finger domain prevent Bmi-1 from binding dinG. This points to a potential requirement for Bmi-1-dinG heterodimerization in Bmi-1-induced lymphomas. We have identified a novel PcG protein, MPc3, that interacts with dinG. Preliminary data indicate that MPc3 is displaced from dinG by Bmi-1. Disruption of the interaction between dinG and MPc3 is dependent upon an intact Bmi-1 RING finger. Thus, mutant Bmi-1 proteins that are non-transforming are predicted to fail to disrupt the dinG-MPc3 dimer. This finding suggests that a dynamic interaction between the PcG proteins may underlie the cellular transformation caused by Bmi-1. Based on the importance of the RING finger domain of Bmi-1 in inducing cellular transformation, in binding dinG, and in displacing MPc3, we propose to study the potential role of dinG and MPc3 in Bmi-1- mediated neoplastic events. We will test the hypothesis that Bmi-1-dinG heterodimerization is required for cellular transformation caused by Bmi-1. We will also examine whether overexpression of Bmi-1 potentially alters the composition of PcG complexes by binding dinG and simultaneously displacing MPc3.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Identification and analysis of a third mouse Polycomb gene, MPc3.
第三个小鼠 Polycomb 基因 MPc3 的鉴定和分析。
DOI:
10.1016/s0378-1119(99)00540-5
发表时间:
2000
期刊:
Gene
影响因子:
3.5
作者:
[Hemenway,CS, Halligan,BW, Gould,GC, Levy,LS]
通讯作者:
Levy,LS
Disrupting the AF4-AF9 protein complex in MLL leukemias.
-
批准号:7350846
-
项目类别:
-
资助金额:$12.92万
-
财政年份:2008
-
负责人:Charles Stanley Hemenway
-
依托单位:
Disrupting the AF4-AF9 protein complex in MLL leukemias.
-
批准号:7585321
-
项目类别:
-
资助金额:$12.92万
-
财政年份:2008
-
负责人:Charles Stanley Hemenway
-
依托单位:
TULANE CANCER GENETICS COBRE: INOVATIVE THERAPIES FOR T(4;11) LEUKEMIA
-
批准号:7720775
-
项目类别:
-
资助金额:$2.82万
-
财政年份:2008
-
负责人:Charles Stanley Hemenway
-
依托单位:
TULANE CANCER GENETICS COBRE: INOVATIVE THERAPIES FOR T(4;11) LEUKEMIA
-
批准号:7610678
-
项目类别:
-
资助金额:$6.28万
-
财政年份:2007
-
负责人:Charles Stanley Hemenway
-
依托单位:
TULANE CANCER GENETICS COBRE: INOVATIVE THERAPIES FOR T(4;11) LEUKEMIA
-
批准号:7382136
-
项目类别:
-
资助金额:$8.63万
-
财政年份:2006
-
负责人:Charles Stanley Hemenway
-
依托单位:
TULANE CANCER GENETICS COBRE: INOVATIVE THERAPIES FOR T(4;11) LEUKEMIA
-
批准号:7171363
-
项目类别:
-
资助金额:$28.57万
-
财政年份:2005
-
负责人:Charles Stanley Hemenway
-
依托单位:
Targeted therapy for 11q23 acute leukemias.
-
批准号:6778991
-
项目类别:
-
资助金额:$20.05万
-
财政年份:2004
-
负责人:Charles Stanley Hemenway
-
依托单位:
Targeted therapy for 11q23 acute leukemias
-
批准号:7731655
-
项目类别:
-
资助金额:$20.3万
-
财政年份:2004
-
负责人:Charles Stanley Hemenway
-
依托单位:
Targeted therapy for 11q23 acute leukemias.
-
批准号:7391927
-
项目类别:
-
资助金额:$9.31万
-
财政年份:2004
-
负责人:Charles Stanley Hemenway
-
依托单位:
Targeted therapy for 11q23 acute leukemias
-
批准号:7848360
-
项目类别:
-
资助金额:$20.3万
-
财政年份:2004
-
负责人:Charles Stanley Hemenway
-
依托单位:
Targeted therapy for 11q23 acute leukemias.
-
批准号:6879649
-
项目类别:
-
资助金额:$20.05万
-
财政年份:2004
-
负责人:Charles Stanley Hemenway
-
依托单位:
Targeted therapy for 11q23 acute leukemias.
-
批准号:7251652
-
项目类别:
-
资助金额:$1.49万
-
财政年份:2004
-
负责人:Charles Stanley Hemenway
-
依托单位:
Targeted therapy for 11q23 acute leukemias.
-
批准号:7028972
-
项目类别:
-
资助金额:$19.58万
-
财政年份:2004
-
负责人:Charles Stanley Hemenway
-
依托单位:
Targeted therapy for 11q23 acute leukemias
-
批准号:8270564
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2004
-
负责人:Charles Stanley Hemenway
-
依托单位:
TULANE CANCER GENETICS COBRE: INOVATIVE THERAPIES FOR T(4;11) LEUKEMIA
-
批准号:6972570
-
项目类别:
-
资助金额:$24.92万
-
财政年份:2004
-
负责人:Charles Stanley Hemenway
-
依托单位:
Targeted therapy for 11q23 acute leukemias
-
批准号:8066438
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2004
-
负责人:Charles Stanley Hemenway
-
依托单位:
BMI1 INTERACTING PROTEINS IN NEOPLASTIC TRANSFORMATION
-
批准号:2908482
-
项目类别:
-
资助金额:$10.68万
-
财政年份:1999
-
负责人:Charles Stanley Hemenway
-
依托单位:
BMI1 INTERACTING PROTEINS IN NEOPLASTIC TRANSFORMATION
-
批准号:6174226
-
项目类别:
-
资助金额:$11.0万
-
财政年份:1999
-
负责人:Charles Stanley Hemenway
-
依托单位:
BMI1 INTERACTING PROTEINS IN NEOPLASTIC TRANSFORMATION
-
批准号:6376806
-
项目类别:
-
资助金额:$13.62万
-
财政年份:1999
-
负责人:Charles Stanley Hemenway
-
依托单位:
海外基金